pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Cardura XL
drug
save

doxazosin mesylate XR

Marketedupdated 3mo ago
by $VTRS Viatris Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 3
  • company$VTRSViatris Inc2 co-mentions · 2 sources
  • tagRecall2 co-mentions · 2 sources
  • drugCardura2 co-mentions · 2 sources

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand
Cardura XL
generic
doxazosin mesylate
indication
Storage Symptoms of Benign Prostatic Hyperplasia
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 28m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?